Neoprobe completes Phase 3 Lymphoseek clinical trial on breast cancer patients

[News]

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, has completed a Phase 3 clinical trial of Lymphoseek® (NEO3-05) with positive results.

More... (http://www.news-medical.net/news/20091209/Neoprobe-completes-Phase-3-Lymphoseek-clinical-trial-on-breast-cancer-patients.aspx)